1972. Continued Rising Mortality from Hepatitis C Virus in the United States, 2003-2013
Session: Oral Abstract Session: The Spectrum of Viral Infection
Saturday, October 10, 2015: 2:00 PM
Room: 32--ABC
Background:   Despite new curative antiviral treatments for hepatitis C virus (HCV) infection, the increasing mortality and health burden for HCV-infected persons remain underappreciated. We examined national multiple-cause-of-death (MCOD) data from 2003-2013 and data from the Chronic Hepatitis Cohort Study (CHeCS) to estimate trends in HCV–related mortality in the United States.

Methods:    ICD-10 codes in the MCOD ‘record axis’ fields were examined for hepatitis C and 59 other nationally notifiable (to CDC) infectious conditions. To calculate mortality rates in MCOD data, deaths associated with HCV infection and the other infectious conditions were divided by the US Census population for each year or, for CHeCS, by the numbers of HCV-infected persons in the cohort in each year. 

Results: From 2003-2013, deaths with hepatitis C recorded on death certificates increased from 11,051 in 2003 to 19,368 in 2013 (Figure;  Cochrane-Armitage trend test, p=0.01), while deaths associated with all 59 other notifiable infectious conditions decreased from 24,434 in 2003 to 18,002 in 2013 (Figure, trend, p=0.06).  In 2012, the number of deaths associated with hepatitis C surpassed that with all 59 other notifiable infectious conditions.  In 2013, 51.1% (n=9,899) of HCV-related deaths occurred among persons aged 55-64 years (mean age, 59.7 years).   Declining mortality trends were observed in  11,000 HCV-infected persons in care in CHeCS.

Conclusion:   Despite improving therapies, deaths from hepatitis C—mainly among persons aged 55-64 years-- continue to rise, indicating the poor penetrance of therapies to the 3 million Americans estimated to be infected with HCV.  Moreover, since only 19% of HCV-infected patients who die have HCV listed anywhere on their death certificate, these data underestimate the problem.  

Figure.  Annual number of deaths from hepatitis C virus and 59 other nationally notifiable infectious conditions listed as multiple causes of death in the United States , 2003- 2013.

                 

Scott D. Holmberg, MD, MPH, FIDSA1, Kathleen Ly, MPH1, Jian Xing, PhD1, Elizabeth Hughes, PhD2, Anne C. Moorman, BSN, MPH1 and Ruth Jiles, PhD, MPH, MS3, (1)Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, GA, (2)Division of Viral Hepatitis, CDC, Atlanta, GA, (3)Div Viral Hepatitis, CDC, Atlanta, GA

Disclosures:

S. D. Holmberg, None

K. Ly, None

J. Xing, None

E. Hughes, None

A. C. Moorman, None

R. Jiles, None

Previous Abstract | Next Abstract >>

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 7th with the exception of research findings presented at the IDWeek press conferences.